Chromadex Corp
NASDAQ:CDXC
Intrinsic Value
The intrinsic value of one
CDXC
stock under the Base Case scenario is
3.43
USD.
Compared to the current market price of 1.7 USD,
Chromadex Corp
is
Undervalued by 51%.
The Intrinsic Value is calculated as the average of the two valuation methods:
Fundamental Analysis
CDXC Profitability Score
Profitability Due Diligence
Chromadex Corp's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Chromadex Corp's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
CDXC Solvency Score
Solvency Due Diligence
Chromadex Corp's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Chromadex Corp's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
Chromadex Corp
CDXC Capital Structure
Chromadex Corp
| Market Capitalization | 116M USD | |
| Total Debt | 0 USD | |
| Minority Interest | 0 USD | |
| Preferred Equity | 0 USD | |
| Cash and Equivalents | 13.1M USD | |
| Short-Term Investments | 0 USD | |
| Enterprise Value | 103M USD | |
Wall St
Price Targets
CDXC Price Targets Summary
Chromadex Corp
According to Wall Street analysts, the average 1-year price target for
CDXC
is 6.18 USD
with a low forecast of 2.12 USD and a high forecast of 10.5 USD.
Competitive Landscape
CDXC Competitors
Chromadex Corp
CDXC Suppliers & Customers
Chromadex Corp
Chromadex Corp has 2 key suppliers from 1 countries and 1 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Retail industry.
Chromadex Corp has 2 key customers from 2 countries and 2 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Retail industry.
Ownership
CDXC Insider Trading
Buy and sell transactions by insiders
During the last 12 months Chromadex Corp insiders bought 1.5M USD , and have not sold any shares. The last transaction was made on Dec 6, 2022 by Fried Robert N (Cheif Executive Officer), who bought 100k USD worth of CDXC shares.
| Date | Value | Insider Name | Amount | Avg Price |
|---|---|---|---|---|
| Sep 30, 2022 |
Buy
100 000
USD
|
Fried Robert N
Cheif Executive Officer
|
-80 000 | 1.25 USD |
| Sep 30, 2022 |
Buy
1 200 000
USD
|
Chau Hoi Shuen Solina Holly
10 percent owner
|
-960 000 | 1.25 USD |
| Jun 16, 2022 |
Buy
99 878
USD
|
Chau Hoi Shuen Solina Holly
10 percent owner
|
-60 037 | 1.6636 USD |
| Mar 16, 2022 |
Buy
54 000
USD
|
Fried Robert N
CEO
|
-25 000 | 2.16 USD |
| May 13, 2021 |
Buy
66 500
USD
|
Fried Robert N
CEO
|
-10 000 | 6.65 USD |
| Mar 16, 2021 |
Sell
263 400
USD
|
Block Stephen A
Director
|
-20 000 | 13.17 USD |
| Mar 15, 2021 |
Sell
62 400
USD
|
Block Stephen A
Director
|
-32 500 | 1.92 USD |
| Dec 10, 2020 |
Sell
196 333
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-37 829 | 5.19 USD |
| Nov 6, 2020 |
Buy
22 150
USD
|
Farr Kevin M
CHIEF FINANCIAL OFFICER
|
-5 000 | 4.43 USD |
| May 19, 2020 |
Buy
4 690
USD
|
Fried Robert N
CEO
|
-1 000 | 4.69 USD |
| Nov 14, 2019 |
Buy
30 900
USD
|
Fried Robert N
CEO
|
-10 000 | 3.09 USD |
| Aug 23, 2019 |
Buy
10 075
USD
|
Fried Robert N
CEO
|
-2 500 | 4.03 USD |
| May 21, 2019 |
Buy
9 981
USD
|
Fried Robert N
CEO
|
-2 253 | 4.43 USD |
| Mar 15, 2019 |
Buy
19 000
USD
|
Fried Robert N
CEO
|
-5 000 | 3.8 USD |
| Mar 15, 2019 |
Buy
0
USD
|
Farr Kevin M
CHIEF FINANCIAL OFFICER
|
-6 900 | USD |
| Mar 14, 2019 |
Buy
26 833
USD
|
Farr Kevin M
CHIEF FINANCIAL OFFICER
|
-6 725 | 3.99 USD |
| Mar 12, 2019 |
Buy
26 426
USD
|
Farr Kevin M
CHIEF FINANCIAL OFFICER
|
-7 300 | 3.62 USD |
| Mar 11, 2019 |
Buy
0
USD
|
Farr Kevin M
CHIEF FINANCIAL OFFICER
|
-5 700 | USD |
| Mar 11, 2019 |
Sell
15 000
USD
|
Block Stephen A
Director
|
-10 000 | 1.5 USD |
| Mar 11, 2019 |
Sell
50 365
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-14 390 | 3.5 USD |
| Sep 11, 2018 |
Buy
17 500
USD
|
Farr Kevin M
CHIEF FINANCIAL OFFICER
|
-5 000 | 3.5 USD |
| May 18, 2018 |
Buy
19 150
USD
|
Farr Kevin M
CHIEF FINANCIAL OFFICER
|
-5 000 | 3.83 USD |
| May 17, 2018 |
Buy
10 800
USD
|
Friedman Mark J
GENERAL COUNSEL
|
-3 000 | 3.6 USD |
| May 16, 2018 |
Buy
15 308
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-4 300 | 3.56 USD |
| May 15, 2018 |
Buy
36 300
USD
|
Fried Robert N
CEO
|
-10 000 | 3.63 USD |
| May 15, 2018 |
Buy
19 855
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-5 500 | 3.61 USD |
| Mar 29, 2018 |
Sell
2 133
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-474 | 4.5 USD |
| Mar 27, 2018 |
Sell
110 601
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-24 578 | 4.5 USD |
| Jan 11, 2018 |
Sell
40 619
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-6 249 | 6.5 USD |
| Jan 10, 2018 |
Sell
99 585
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-22 130 | 4.5 USD |
| Dec 21, 2017 |
Sell
262 800
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-58 400 | 4.5 USD |
| Nov 17, 2017 |
Buy
2 999 999
USD
|
Champion River Ventures Ltd
10 percent owner
|
-731 707 | 4.1 USD |
| Aug 25, 2017 |
Buy
6 620
USD
|
Allen Stephen R.
Director
|
-2 000 | 3.31 USD |
| Aug 18, 2017 |
Buy
2 044 034
USD
|
Pioneer Step Holdings Ltd
10 percent owner
|
-786 167 | 2.6 USD |
| Aug 18, 2017 |
Buy
3 066 050
USD
|
Champion River Ventures Ltd
10 percent owner
|
-1 179 250 | 2.6 USD |
| Aug 15, 2017 |
Buy
31 500
USD
|
Fried Robert N
CEO
|
-10 000 | 3.15 USD |
| May 24, 2017 |
Buy
6 555 968
USD
|
Pioneer Step Holdings Ltd
10 percent owner
|
-2 521 526 | 2.6 USD |
| May 24, 2017 |
Buy
9 833 949
USD
|
Champion River Ventures Ltd
10 percent owner
|
-3 782 288 | 2.6 USD |
| May 19, 2017 |
Buy
9 600
USD
|
Allen Stephen R.
Director
|
-3 000 | 3.2 USD |
| Mar 20, 2017 |
Buy
5 620
USD
|
Allen Stephen R.
Director
|
-2 000 | 2.81 USD |
| Dec 12, 2016 |
Buy
4 840
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-2 000 | 2.42 USD |
| Sep 1, 2016 |
Buy
4 980
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-1 500 | 3.32 USD |
| Sep 1, 2016 |
Buy
50 850
USD
|
Fried Robert N
CEO
|
-15 000 | 3.39 USD |
| Jun 20, 2016 |
Buy
27 082
USD
|
Rhonemus Troy Allen
EXECUTIVE VICE PRESIDENT
|
-7 800 | 3.472 USD |
| Jan 29, 2016 |
Sell
6 379
USD
|
Fried Robert N
CEO
|
-5 063 | 1.26 USD |
| Dec 15, 2014 |
Buy
9 400
USD
|
Rhonemus Troy Allen
EXECUTIVE VICE PRESIDENT
|
-10 000 | 0.94 USD |
| Aug 26, 2014 |
Buy
2 750
USD
|
Rhonemus Troy Allen
EXECUTIVE VICE PRESIDENT
|
-2 500 | 1.1 USD |
| Aug 25, 2014 |
Buy
2 453
USD
|
Varvaro Thomas C
CFO, TREASURER AND SECRETARY
|
-2 250 | 1.09 USD |
| Aug 22, 2014 |
Buy
1 500
USD
|
Varvaro Thomas C
CFO, TREASURER AND SECRETARY
|
-1 250 | 1.2 USD |
| Aug 22, 2014 |
Buy
5 800
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-5 000 | 1.16 USD |
| Aug 22, 2014 |
Buy
3 000
USD
|
Rhonemus Troy Allen
EXECUTIVE VICE PRESIDENT
|
-2 500 | 1.2 USD |
| May 13, 2013 |
Buy
16 550
USD
|
Brauser Michael
Director
|
-25 000 | 0.662 USD |
| Apr 30, 2013 |
Buy
2 752
USD
|
Honig Barry C
Director
|
-4 300 | 0.64 USD |
| Apr 29, 2013 |
Buy
30 036
USD
|
Honig Barry C
Director
|
-47 600 | 0.631 USD |
| Apr 26, 2013 |
Buy
30 033
USD
|
Honig Barry C
Director
|
-47 900 | 0.627 USD |
| Apr 25, 2013 |
Buy
9 548
USD
|
Honig Barry C
Director
|
-15 400 | 0.62 USD |
| Dec 19, 2012 |
Buy
9 300
USD
|
Honig Barry C
Director
|
-15 000 | 0.62 USD |
| Dec 14, 2012 |
Buy
18 207
USD
|
Honig Barry C
Director
|
-28 900 | 0.63 USD |
| Nov 16, 2012 |
Buy
15 500
USD
|
Honig Barry C
Director
|
-25 000 | 0.62 USD |
| Sep 11, 2012 |
Buy
5 775
USD
|
Honig Barry C
Director
|
-7 500 | 0.77 USD |
| Aug 31, 2012 |
Buy
6 500
USD
|
Brauser Michael
Director
|
-10 000 | 0.65 USD |
| Aug 31, 2012 |
Buy
4 526
USD
|
Honig Barry C
Director
|
-7 300 | 0.62 USD |
| Aug 15, 2012 |
Buy
11 100
USD
|
Honig Barry C
Director
|
-15 000 | 0.74 USD |
| Aug 13, 2012 |
Buy
19 800
USD
|
Honig Barry C
Director
|
-30 000 | 0.66 USD |
| Jul 5, 2012 |
Buy
6 694
USD
|
Honig Barry C
Director
|
-9 991 | 0.67 USD |
| Jul 3, 2012 |
Buy
5 699
USD
|
Honig Barry C
Director
|
-8 506 | 0.67 USD |
| Jun 20, 2012 |
Buy
48 612
USD
|
Honig Barry C
Director
|
-74 787 | 0.65 USD |
| Jun 20, 2012 |
Buy
54 274
USD
|
Brauser Michael
Director
|
-83 498 | 0.65 USD |
| Jun 20, 2012 |
Buy
390 000
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-600 000 | 0.65 USD |
| Jun 13, 2012 |
Buy
3 600
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-5 000 | 0.72 USD |
| Jun 13, 2012 |
Buy
21 125
USD
|
Honig Barry C
Director
|
-32 500 | 0.65 USD |
| Jun 13, 2012 |
Buy
7 000
USD
|
Brauser Michael
Director
|
-10 000 | 0.7 USD |
| May 30, 2012 |
Buy
7 000
USD
|
Honig Barry C
Director
|
-10 000 | 0.7 USD |
| May 29, 2012 |
Buy
3 500
USD
|
Honig Barry C
Director
|
-5 000 | 0.7 USD |
| May 18, 2012 |
Buy
4 080
USD
|
Honig Barry C
Director
|
-8 000 | 0.51 USD |
| May 16, 2012 |
Buy
12 300
USD
|
Honig Barry C
Director
|
-24 600 | 0.5 USD |
| May 16, 2012 |
Buy
2 700
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-5 000 | 0.54 USD |
| Feb 23, 2012 |
Buy
0
USD
|
Himmel Jeffrey
CHIEF EXECUTIVE OFFICER
|
-1 000 000 | USD |
| Feb 10, 2012 |
Buy
250 000
USD
|
Honig Barry C
Director
|
-333 333 | 0.75 USD |
| Feb 10, 2012 |
Buy
49 999
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-66 665 | 0.75 USD |
| Feb 10, 2012 |
Buy
1 000 000
USD
|
Himmel Jeffrey
CHIEF EXECUTIVE OFFICER
|
-1 333 333 | 0.75 USD |
| Feb 10, 2012 |
Buy
150 000
USD
|
Halpryn Glenn L
Director
|
-200 000 | 0.75 USD |
| Feb 10, 2012 |
Buy
150 000
USD
|
Brauser Michael
Director
|
-200 000 | 0.75 USD |
| Feb 10, 2012 |
Buy
250 000
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-333 333 | 0.75 USD |
| Dec 9, 2011 |
Buy
1 300
USD
|
Varvaro Thomas C
CFO, TREASURER AND SECRETARY
|
-2 000 | 0.65 USD |
| Dec 8, 2011 |
Buy
18 000
USD
|
Spengler William
PRESIDENT
|
-30 000 | 0.6 USD |
| Dec 7, 2011 |
Buy
945
USD
|
Varvaro Thomas C
CFO, TREASURER AND SECRETARY
|
-1 500 | 0.63 USD |
| Dec 7, 2011 |
Buy
4 500
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-7 500 | 0.6 USD |
| Nov 22, 2011 |
Sell
4 752
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-5 400 | 0.88 USD |
| Jul 13, 2011 |
Buy
21 000
USD
|
Brauser Michael
Director
|
-100 000 | 0.21 USD |
| Jun 1, 2011 |
Buy
13 800
USD
|
Spengler William
PRESIDENT
|
-10 000 | 1.38 USD |
| May 25, 2011 |
Buy
14 000
USD
|
Spengler William
PRESIDENT
|
-10 000 | 1.4 USD |
| May 24, 2011 |
Buy
4 590
USD
|
Spengler William
PRESIDENT
|
-3 400 | 1.35 USD |
| May 18, 2011 |
Buy
14 500
USD
|
Spengler William
PRESIDENT
|
-10 000 | 1.45 USD |
| Feb 4, 2011 |
Buy
7 670
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-5 000 | 1.534 USD |
| Feb 3, 2011 |
Buy
7 960
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-5 000 | 1.592 USD |
| Feb 2, 2011 |
Buy
7 960
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-5 000 | 1.592 USD |
| Feb 1, 2011 |
Buy
8 230
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-5 000 | 1.646 USD |
| Jan 31, 2011 |
Buy
8 230
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-5 000 | 1.646 USD |
| Dec 9, 2010 |
Buy
4 470
USD
|
Brauser Michael
Director
|
-3 000 | 1.49 USD |
| Dec 8, 2010 |
Buy
7 500
USD
|
Jaksch Frank L Jr
EXECUTIVE CHAIRMAN OF BOARD
|
-5 000 | 1.5 USD |
| Dec 8, 2010 |
Buy
3 120
USD
|
Brauser Michael
Director
|
-2 000 | 1.56 USD |
| Nov 22, 2010 |
Buy
8 000
USD
|
Brauser Michael
Director
|
-5 000 | 1.6 USD |
| Sep 30, 2010 |
Buy
520 000
USD
|
Frost Phillip Md Et Al
10 percent owner
|
-800 000 | 0.65 USD |
| Jul 16, 2008 |
Buy
2 625
USD
|
Chassman Margie
10 percent owner
|
-1 000 | 2.625 USD |
Shareholder Return
CDXC Price
Chromadex Corp
| Average Annual Return | -2.47% |
| Standard Deviation of Annual Returns | 31.15% |
| Max Drawdown | -94% |
| Market Capitalization | 116M USD |
| Shares Outstanding | 74 468 704 |
| Percentage of Shares Shorted | 2.81% |
Company Profile
Chromadex Corp
Country
Industry
Market Cap
Dividend Yield
Description
Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.
Contact
IPO
Employees
Officers
The intrinsic value of one
CDXC
stock under the Base Case scenario is
3.43
USD.
Compared to the current market price of 1.7 USD, Chromadex Corp is Undervalued by 51%.
